Endoscopy 2019; 51(04): 365-388
DOI: 10.1055/a-0859-1883
DOI: 10.1055/a-0859-1883
Guideline
Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019
Autoren
-
Pedro Pimentel-Nunes
1 Gastroenterology Department, Portuguese Oncology Institute of Porto, Portugal2 Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal3 Surgery and Physiology Department, Faculty of Medicine of the University of Porto, Porto, Portugal, -
Diogo Libânio
1 Gastroenterology Department, Portuguese Oncology Institute of Porto, Portugal2 Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal -
Ricardo Marcos-Pinto
2 Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal4 Department of Gastroenterology, Porto University Hospital Centre, Institute of Biomedical Sciences, University of Porto (ICBAS/UP), Portugal -
Miguel Areia
2 Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal5 Gastroenterology Department, Portuguese Oncology Institute of Coimbra, Portugal -
Marcis Leja
6 Institute of Clinical and Preventive Medicine, University of Latvia, Digestive Diseases Center, GASTRO, Riga, Latvia -
Gianluca Esposito
7 Department of Medicine, Surgery and Translational Medicine University Hospital Sant’Andrea, University Sapienza Roma, Rome, Italy -
Monica Garrido
4 Department of Gastroenterology, Porto University Hospital Centre, Institute of Biomedical Sciences, University of Porto (ICBAS/UP), Portugal -
Ilze Kikuste
6 Institute of Clinical and Preventive Medicine, University of Latvia, Digestive Diseases Center, GASTRO, Riga, Latvia -
Francis Megraud
8 INSERM U1053, Université de Bordeaux and CHU Pellegrin, Laboratoire de Bacteriologie, Bordeaux, France -
Tamara Matysiak-Budnik
9 IMAD, Hepato-Gastroenterology and Digestive Oncology, CHU de Nantes, University of Nantes, France -
Bruno Annibale
7 Department of Medicine, Surgery and Translational Medicine University Hospital Sant’Andrea, University Sapienza Roma, Rome, Italy -
Jean-Marc Dumonceau
10 Gedyt Endoscopy Center, Buenos Aires, Argentina -
Rita Barros
11 Institute of Molecular Pathology and Immunology at the University of Porto (Ipatimup), Porto, Portugal12 Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal -
Jean-François Fléjou
13 Service d’Anatomie Pathologique, Hôpital Saint-Antoine, AP-HP, Faculté de Médecine Sorbonne Université, Paris, France -
Fátima Carneiro
11 Institute of Molecular Pathology and Immunology at the University of Porto (Ipatimup), Porto, Portugal12 Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal14 Pathology Department, Centro Hospitalar de São João and Faculty of Medicine, Porto, Portugal -
Jeanin E. van Hooft
15 Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, The Netherlands -
Ernst J. Kuipers
16 Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands -
Mario Dinis-Ribeiro
1 Gastroenterology Department, Portuguese Oncology Institute of Porto, Portugal2 Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal

